While sales compensation design for any product launch can be incredibly challenging, it is especially complex for products that treat rare and orphan diseases. In this blog post, we explore three sales compensation pitfalls to avoid for the launch of a rare disease product.

Although the forced rank sales compensation plan is one of the most popular designs utilized for a biopharma product launch, the launch stage is actually the stage in which forced rank does the most harm. In this blog post, we explore why you should avoid forced rank sales compensation plans for a product launch.

Critical to the success of a multi-product bag is ensuring that all products get sufficient attention without taking focus away from the product(s) deemed most important. However, there are number of sales compensation pitfalls that make achieving this very challenging. In this blog post, we outline what they are and how to navigate them.

Targeting the right physicians for a biopharma product launch is critical to getting the product out of the gates quickly and achieving fast adoption. In this blog post, we explore why your physician segmentation and targeting methodology needs to go beyond standard methodologies to drive sales for a new product launch.

Let’s investigate the limitations of the most common way to score MBOs as well as two innovative scoring strategies that drive superior accountability and performance.

A successful launch is critical to ensuring a product’s longevity in the marketplace. Let’s explore why you shouldn’t adopt some of most common solutions to three sales compensation challenges for product launches.